Navigation Links
Melatonin Hormone Found in Red Wine Grapes

According to the research conducted by the scientist Iriti Marcello at the University of Milan it was found that grapes used in the making //of red wine have high levels of melatonin. The study results were published in the journal of science of food and Agriculture. This is a hormone which is secreted by the pineal gland in the brain in all mammals. But now the hormone’s existence in plants has shocked the researcher. It is otherwise called the sleep hormone. It is produced by the body in the night and it regulated the circadian rhythm meaning it tells the body when it is time to sleep. Hence the researches in Italy explain the reason as to why people fall asleep after drinking wine.

The hormone plays a vital role in the sleep-wake patterns and also has antioxidant properties. Some of the grape varieties which have high content of melatonin are Nebbolo, Merlot, Cabernet Savignon, Sangiovesse and Croatina. According to the researchers it was found that the melatonin content could be enhanced in grapes by treating them with a plant vaccine Benzothiadiazole. But Richard Wurtman of the brain and cognitive science department at MIT feels that further in depth investigation has to be done to prove that the substance found in the grapes is melatonin and not any other substance which is similar to the hormone.


'"/>




Page: 1

Related medicine news :

1. Report on the Safety and Effectiveness of Melatonin supplements
2. Melatonin Can Help Nighttime Workers Sleep
3. Is Melatonin Effective For Sleep
4. High Melatonin can Help Delay Ageing
5. Levothyroxine Thyroid Hormone Replacement, Approved for Hypothyroidism
6. Hormone replacement Therapy a headache
7. Ovarian cancer in relationship with Hormone therapy
8. Hormone contraceptives lead to bone problems
9. Hormone treatment helps obese people slim down
10. Hormone Deficiency Results In Miscarriage
11. Hormones Linked To Migraines
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Melatonin Hormone Found Red Wine Grapes

(Date:12/2/2008)...Provides Online Resource and Fire Safety Tips for ... Boston, MA (PRWEB) December 2, 2008 --...ete , actress, philanthropist and mother of four, ...a few moments before the holiday rush to review fi...Smart.com. , , , , ,Home fires top the list of Am...
(Date:12/1/2008)...Patient satisfaction scores at,outpatient health ... report,from Press Ganey Associates, Inc. The 20...on American Health Care cites increased competitio... patient services. The report,includes responses... than,1,200 outpatient care facilities nationwide...
(Date:12/1/2008)...e availability of a portable eight-slice computed ...ignificantly increase the number of stroke victims...Results of the study, conducted at North Shore Med... will be presented today at the annual meeting of ... , "The hospital,s acquisition of a portable CT ...
(Date:12/1/2008)...nection between second-hand smoke and coronary hea...s passed to reduce such passive smoking, exposures... January 2009 issue of the American Journal of Pr...y of California, San Francisco, Partners Healthcar...d the CHD Policy Model to better predict future tr...
Breaking Medicine News(10 mins):Health News:Liberty Mutual and Holly Robinson Peete Team Up to Remind Families to Be Fire Smart this Holiday Season with Tips on Fire Safety 2Health News:Liberty Mutual and Holly Robinson Peete Team Up to Remind Families to Be Fire Smart this Holiday Season with Tips on Fire Safety 3Health News:Liberty Mutual and Holly Robinson Peete Team Up to Remind Families to Be Fire Smart this Holiday Season with Tips on Fire Safety 4Health News:Outpatient Service Facilities Face Increasing Competition - Patient Perceptions More Important Than Ever 2Health News:Portable CT increases chance of stroke survival and recovery 2
...e city's health services panel Friday approved a p...fixed fine for anyone who breaches tough new anti-...rafted in to back up the teams of tobacco control ...ponsibility of enforcing the no-smoking policy. S...
... researchers have found evidence that tropical cyc... ocean circulation patterns that transport heat a...e. According to Matthew Huber, Purdue University ...ciences who led the research group, the findings s...
...Over one hundred Long Island AARP members gathered...n before the end of the 2007 Legislative Session i...ore affordable and help assure that their cell pho...heir message directly to their legislators during ...
...aken up a rather strange hobby to help her keep fi...ly revealed that she has taken to the trapeze to k...for your confidence and amazing for your body but ... do something that pushed me,' the Daily Express q...
Other Medicine News:Health News:Tropical Cyclones Play Important Role in Climate-control 2Health News:Long Island Seniors Rally for Rx Affordable Prescription Drugs and Cell Phone Protections 2
(Date:11/25/2008)...l Trial to Assess Survival of Patients Receiving L...able Hepatocellular Carcinoma , , BELLEVUE,...ology, Inc. (LSO) today announced the completion o... Light Infusion Therapy(TM) (Litx(TM)) as a treatm...), also known as hepatoma or primary liver cancer....
(Date:11/24/2008)...n, Nov. 24 Takeda Pharmaceutical C...keda Global Research & Development Center, Inc...ry Committee of the U.S. Food and Drug Administrat...tat for the treatment of hyperuricemia in patient...pproval, with one panel member abstaining. The vot...
(Date:11/24/2008)...swire-FirstCall/ -- Leaders of Schering-Plough Cor...or investors on the company,s research pipeline, h...ncludes 46 new entities in clinical trials or unde... , , "Research and development is adding st...ue our transformation," said Fred Hassan, chairman...
(Date:11/24/2008)... leadership and long-term commitment to hepatitis ...ewswire-FirstCall/ -- Schering-Plough Corporation ... boceprevir, its lead investigational oral hepatit...elopment. The company believes boceprevir has the...s protease inhibitor for treating chronic hepatiti...
Breaking Medicine Technology:Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 2Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 3Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 4Arthritis Advisory Committee Recommends FDA Approval of Febuxostat for the Treatment of Hyperuricemia in Patients With Gout 2Arthritis Advisory Committee Recommends FDA Approval of Febuxostat for the Treatment of Hyperuricemia in Patients With Gout 3Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects 2Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects 3Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects 4Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects 5Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 2Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 3Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 4Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 5Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 6Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 7Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 8Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 9ISTA Pharmaceuticals Announces Receipt of Subpoena Relating to Promotional Practices for XIBROM 28TM 29 16447 1ISTA Pharmaceuticals Announces Receipt of Subpoena Relating to Promotional Practices for XIBROM 28TM 29 16447 2ISTA Pharmaceuticals Announces Receipt of Subpoena Relating to Promotional Practices for XIBROM 28TM 29 16447 3Frito Lay Launches Low Sodium Versions of its Top Selling Snack Chips 16445 1Frito Lay Launches Low Sodium Versions of its Top Selling Snack Chips 16445 2Millennium Announces VELCADE 28R 29 28Bortezomib 29 for Injection First Quarter 2008 U S Net Sales 4507 1Millennium Announces VELCADE 28R 29 28Bortezomib 29 for Injection First Quarter 2008 U S Net Sales 4507 2Millennium Announces VELCADE 28R 29 28Bortezomib 29 for Injection First Quarter 2008 U S Net Sales 4507 3Millennium Announces VELCADE 28R 29 28Bortezomib 29 for Injection First Quarter 2008 U S Net Sales 4507 4Millennium Announces VELCADE 28R 29 28Bortezomib 29 for Injection First Quarter 2008 U S Net Sales 4507 5Millennium Announces VELCADE 28R 29 28Bortezomib 29 for Injection First Quarter 2008 U S Net Sales 4507 6Millennium Announces VELCADE 28R 29 28Bortezomib 29 for Injection First Quarter 2008 U S Net Sales 4507 7Its neck and neck down the long stretch for 2 stroke prevention procedures 16443 1Its neck and neck down the long stretch for 2 stroke prevention procedures 16443 2Its neck and neck down the long stretch for 2 stroke prevention procedures 16443 3Its neck and neck down the long stretch for 2 stroke prevention procedures 16443 4
...il 20,2007-The U.S. Food and Drug,Administration (...sumers to the availability of audio broadcasts tha...oadcasts, commonly known as,podcasts, can be trans...ayers. , The service is part of the agency,s ongoi... concerning the safety of,marketed medications whe...
...at 160th Annual Meeting of the American,Psychiatri...re-FirstCall/ -- In adults with,major depressive d...rapy (ADT) resulted in significant improvement in ...ssion Rating Scale (MADRS),Total Score. In this si...nted here at the 160th Annual Meeting of the Ameri...
Other Medicine Technology:FDA Announces Audio Broadcasts on Emerging Drug Safety Information 2Six-Week Investigational Study In Adults With Major Depressive,Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole,Therapy With Antidepressants 2Six-Week Investigational Study In Adults With Major Depressive,Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole,Therapy With Antidepressants 3Six-Week Investigational Study In Adults With Major Depressive,Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole,Therapy With Antidepressants 4Six-Week Investigational Study In Adults With Major Depressive,Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole,Therapy With Antidepressants 5Six-Week Investigational Study In Adults With Major Depressive,Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole,Therapy With Antidepressants 6Six-Week Investigational Study In Adults With Major Depressive,Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole,Therapy With Antidepressants 7Six-Week Investigational Study In Adults With Major Depressive,Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole,Therapy With Antidepressants 8
For administering anesthetic agents into the posterior sub-Tenon's space 20G x 1in (.90 x 25mm)
For injecting anesthetics into the muscle cone. 23G x 1 1/2 in (.60 x 38mm)
...single plane C-arm angiography system is designed ...mance and an expansive range of diagnostic and int...y to ECG triggered. Outstanding image quality ...ynamic Flat Detector technology, high frequency X-...
...ronystagmography) is a complete vestibular diagnos...eye movements collected via electrodes. Its Window...cade, tracking and Slow Phase Velocity analyses ar...aphic comparison of results to normative data. A p...
Medicine Products: